Christopher Bellamy

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Tanzina Haque, Gwen Wilkie, Marie M. Jones et al. · Blood · 2007 · 637 citations

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

Anthony J. Demetris, Christopher Bellamy, Stefan G. Hübscher et al. · American Journal of Transplantation · 2016 · 606 citations · Full text

Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection

Anthony J. Demetris, David Adams, Christopher Bellamy et al. · Hepatology · 2000 · 537 citations · Full text

Transplant Rejection, Transplantation, Hepatology +12

Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm

Jayne L. Dennis, Torgeir R. Hvidsten, Ernst C. Wit et al. · Clinical Cancer Research · 2005 · 326 citations · Full text

Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization

Christopher Bellamy, C. McDonald, Donald M. Salter et al. · Human Pathology · 1993 · 252 citations

Histologic Categorization, Breast Oncology, Surgical Pathology +7